MUC16 promotes epithelial mesenchymal transformation (EMT) and PDAC cell metastasis by upregulating the expression of cytoskeletal proteins Actg2, MYH11, and Pdlim3, and has been found to alter the tumor microenvironment in pancreatic cancer progression [51]. Here, MUC16 is linked to neoplasm.